Skip to main content
. 2016 Apr 18;7(18):24983–24994. doi: 10.18632/oncotarget.8804

Figure 6. PHA767491 dominantly dampens CDK942 in CD4+ T cells.

Figure 6

A. Western blot detection of RNA Pol II, CDK955, CDK942 and β-actin expression in antigen-activated (2 μg/ml anti-CD3 mAb and 1 μg/ml anti-CD28 mAb) CD4+ T cells pretreated with 3 μM PHA767491 or PBS for 2 h. B.-D. The blot and gray value are shown. Similar results were observed in three independent experiments. **p < 0.01.